Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors-Reference-Cited by-同舟云学术

Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors

Published:2012-08-25 Issue:12 Volume:51 Page:1133-1143
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Poeta Maria Luana,Massi Emanuela,Parrella Paola,Pellegrini Pasquale,De Robertis Mariangela,Copetti Massimiliano,Rabitti Carla,Perrone Giuseppe,Muda Andrea Onetti,Molinari Francesca,Zanellato Elena,Crippa Stefano,Caputo Damiano,Caricato Marco,Frattini Milo,Coppola Roberto,Fazio Vito Michele

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/gcc.21998/fullpdf

Reference59 articles.

1. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression;Abd Hamid;Glycobiology,2008

2. Glycomics and disease markers;An;Curr Opin Chem Biol,2009

3. Growth retardation and early death of b1,4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells;Asano;EMBO J,1997

4. Epigenetic gene regulation in cancer;Ballestar;Adv Genet,2008

5. Worldwide variations in colorectal cancer;Center;CA Cancer J Clin,2009

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B4GALT1-dependent galectin-8 binding with TGF-β receptor suppresses colorectal cancer progression and metastasis;Cell Death & Disease;2024-09-04

2. Central Role of β-1,4-GalT-V in Cancer Signaling, Inflammation, and Other Disease-Centric Pathways;International Journal of Molecular Sciences;2023-12-29

3. Analysis of the Interaction of UBE2Q1 with B4GALT1 and P53: Experimental and Molecular Modeling Study;Protein & Peptide Letters;2023-09-06

4. A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer;Frontiers in Oncology;2023-03-01

5. Upregulation of YKL-40 Promotes Metastatic Phenotype and Correlates with Poor Prognosis and Therapy Response in Patients with Colorectal Cancer;Cells;2022-11-11